Counterpath (CPAH) Reports Q1 Loss of $0.05/Share

Counterpath (NASDAQ: CPAH) reported Q1 EPS of ($0.05), versus ($0.06) reported last year. Revenue for the quarter came in at $3.1 million, versus $3 million reported last year.

For earnings history and earnings-related data on Counterpath (CPAH) click here.

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• Aebi Schmidt Holding AG (AEBI) Reports Q2 results; offers guidance
• Madison Square Garden Sports Corp. (MSGS) Tops Q4 EPS by 62c